RH-PRIVÉ
RH Privé, the leading developer of eco luxury homes on the Costa del Sol, has called on the acclaimed design studio Pininfarina for an exclusive conceptual interior design project. With designs of some of the most iconic sports cars in the automotive history and outstanding architectural projects such as the majestic ICONIC tower in Dubai in his charge, this collaboration aims to further enhance the exclusivity and luxury of the developer's most exclusive development: Carat Sky Villas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806233462/en/
RH Privé unveils two of the world’s most desirable luxury penthouses in Costa del Sol. (Photo: RH Privé)
The penthouses are currently under construction, with delivery expected by the end of the year. In their initial conceptualization, the orientation of each dwelling has played a fundamental role, one ‘floating on the sea’ and the other ‘immersed in the mountains’. Each penthouse has been designed based on a well-differentiated conceptual theme: the first incorporates nautical motifs and the second is inspired by different wood textures, with the intention of integrating nature into the home.
“We are proud to partner with Pininfarina. Our union has allowed us not only to align our values, but also to share experiences, ideas and cultures to result in the project of two exclusive penthouses, unique in Spain”, says Guillermo Rodríguez, CEO of RH Privé.
Carat Sky Villas: a unique experience with sustainability as its core
Both penthouses belong to Carat Sky Villas and are strategically located in the majestic enclave of Reserva del Higuerón, where residents can enjoy the best views of the Mediterranean Sea from the Costa del Sol, as well as large open garden spaces alligned with nature.
Talking about sustainability, Carat Sky Villas stands out for its water saving system based on the reuse of rainwater, decalcification and hydro-efficient taps. It also stands out for its maximum energy efficiency model based on an aerothermal system, individual ventilation and the use of large windows to make the most of natural light. Besides, apart from recycling 70% of the construction materials, RH Privé guarantees respect for the biodiversity of the environment by planting native species in the landscaping design and reforesting the area surrounding the development.
In addition, the homes will benefit from the installation of the latest technology on the market, with a domotic system that allows the control of lighting, access and air conditioning, among many other functions, being able to control everything remotely at any time.
Interior design philosophy and superb amenities
In the heart of these penthouses, borders do not exist, overcoming limits and creating spaces for unique moments. The Sea plays a fundamental role in the design of the spaces. The floors are oriented towards the sea, creating spaces flooded with natural light and offering unforgettable sunsets. Thanks to the large windows, the line between indoors and outdoors is blurred, accentuating the sensation of floating above the sea provided by the infinity pool.
Carat’s welcomes you to the community in which only a select few can live. An excellent wellness area consisting of a salt cave, massage room, hammam, sauna and an indoor heated pool that completes the spa area. For the sportiest Carat offers a luxury gym equipped with Technogym machines, featuring its exclusive Christian Dior equipment. Owners can also enjoy the cinema room, a coworking area with sea views and an outdoor space consisting of an infinity pool, pool bar and solarium. But that's not all, as the promotion will feature a 5-star concierge service, allowing owners to forget about tedious chores.
Download the complete image asset of the interiors here.
About RH Privé
RH Privé is the leading real estate promoter in sustainable luxury development in Spain. After more than 30 years of success in Reserva del Higuerón, in the heart of Costa del Sol, the figures speak for themselves: more than 500 homes delivered, more than 200 under construction and more than 160 recently launched on the market. Always committed to eco-luxury development, each construction enjoys the unique stamp of RH Privé under ESG criteria. With a future full of new projects and ambitions, sustainability plays and will play a key role at the heart of the company.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806233462/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom